Top

Published in:

01-12-2021 | Cancer Fatigue | Review Article

The use of guarana (Paullinia cupana) as a dietary supplement for fatigue in cancer patients: a systematic review with a meta-analysis

Authors: Daise Pereira de Araujo, Paula Tâmara Vieira Teixeira Pereira, Ariadina Jansen Campos Fontes, Karla Danielle Silva Marques, Érica Brandão de Moraes, Rosane Nassar Meireles Guerra, João Batista Santos Garcia

Published in: Supportive Care in Cancer | Issue 12/2021

Abstract

Objective

The objective of the present study was to carry out a systematic review with a meta-analysis to assess evidence about the use of guarana fruit to manage fatigue in cancer patients.

Methodology

The data were extracted from the EMBASE, Scopus, MEDLINE, CENTRAL, and CINAHL databases, in any language, using the descriptors “neoplasms” and “Paullinia” or “guarana powder” and “placebos” and “fatigue”. Searches were also conducted to identify any grey literature. Clinical studies with patients who presented cancer-related fatigue as a primary outcome and who used guarana as a dietary supplement were included. The risk of bias in randomized clinical trials was analyzed according to the Cochrane recommendations. The quality of the evidence was assessed using the GRADE system. For studies with the same types of tumors and treatments, meta-analysis was also conducted.

Results

A total of 383 studies were found and, of these, seven were included in the review, for a total of 427 cancer patients. The instruments used to analyze fatigue were the Brief Fatigue Inventory (BFI), the Chalder Fatigue Scale, the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-FATIGUE), and the Piper Scale. Some studies presented a low risk of bias for all the categories. Meta-analysis was conducted for three studies about breast cancer, which presented sufficient data. The use of guarana did not reduce cancer-related fatigue compared with placebo groups (mean of − 0.02 [95% CI − 1.54, 1.50]; p = 0.98) and the quality of evidence according to GRADE was very low.

Conclusion

Dietary supplements are used to improve cancer-related fatigue. The results of this review showed that the use of guarana was not superior to the placebo groups, pointing to the need for further studies with better methodological quality.

Available only for authorised users

Wang XS, Woodruff JF (2015) Gynecologic oncology cancer-related and treatment-related fatigue. Gynecol Oncol [Internet]. 136(3):446–52. https://doi.org/10.1016/j.ygyno.2014.10.013CrossRefPubMed

de Oliveira Campos MP, Riechelmann R, Martins LC, Hassan BJ, Casa FBA, Del Giglio A (2011) Guarana (Paulliniacupana) improves fatigue in breast cancer patients undergoing systemic chemotherapy. J Altern Complement Med 17(6):505–12CrossRef

Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, Wallace EP (1993) Development of a fatigue scale. J Psychosom Res 37(2):147–153. https://doi.org/10.1016/0022-3999(93)90081-p

Gutstein HB (2000) The biologic basis of fatigue. Cancer 92(6 Suppl):1678–1683

Cleeland CS, Bennett GJ, Dantzer R, Dougherty PM, Dunn AJ, Meyers CA et al (2003) Os sintomas do câncer e do tratamento do câncer são devidos a um mecanismo biológico compartilhado? Câncer 97(11):2919–2925PubMed

Marrs JA, Madden J, Newton S (2006) Why am i so tired all the time? Understanding cancer-related fatigue. Clin J Oncol Nurs 10(5):659–661. https://doi.org/10.1188/06.cjon.659-661CrossRef

Wang XS (2008) Fisiopatologia da fadigarelacionadaaocâncer. Clin Oncol Nurs J 12(5 Suppl):11–20CrossRef

Pereira PTVT, Reis AD, Diniz RR et al (2018) Suplementos alimentares e fadiga em pacientes com câncer de mama: uma revisão sistemática. Breast Cancer Res Treat 171:515–526. https://doi.org/10.1007/s10549-018-4857-0CrossRefPubMed

Mustian KM, Sprod LK, Janelsins M, Peppone LJ, Mohile S (2012) Recomendações de exercícios para fadigarelacionada ao câncer, comprometimento cognitivo, problemas de sono, depressão, dor, ansiedade e disfunçãofísica: umarevisão. Oncol Hematol Rev 8(2):81–88PubMedPubMedCentral

10.

Velthuis MJ, Agasi-Idenburg SC, Aufdemkampe G, Wittink HM (2010) O efeito do exercício físico na fadiga relacionada ao câncer durante o tratamento do câncer: uma metanálise de ensaios clínicos randomizados. Clin Oncol 22(3):208–221CrossRef

11.

Sette CVM et al (2018) Purified dry Paulliniacupana (PC-18) extract for chemotherapy-induced fatigue: results of two double-blind randomized clinical trials. J Diet Suppl. 15(5):673–683. https://doi.org/10.1080/19390211.2017.1384781CrossRefPubMed

12.

Martins SPS, Ferreira CLE, Del Giglio A (2017) Estudo randomizado, duplo-cego, controlado por placebo, de um extrato de guaraná seco em pacientes com tumores de cabeça e pescoçosubmetidos à quimioradioterapia: efeitos sobre fadiga e qualidade de vida, revista de suplementos alimentares. 14(1): 32–41. https://doi.org/10.1080/19390211.2016.1193081

13.

del Giglio A, Cubero D, Lerner T, Guariento R, Azevedo R, Psaiva H, Goldman C, Carelli B, Cruz F, Schindler F, Pianowski L, Matos L, Giglio A (2013) Purified dry extract of Paullinia cupana (Guaraná) (PC-18) for chemotherapy-related fatigue in patients with solid tumors: an early discontinuation study. J Diet Suppl 10:325–334. https://doi.org/10.3109/19390211.2013.830676CrossRefPubMed

14.

National Plant Germplasm System, Agricultural Research Service, United States Department of Agriculture (USDA). Germplasm Resources Information Network (GRIN-Taxonomy); National Germplasm Resources Laboratory: Beltsville, MD, 2019; Disponível em: <https://npgsweb.ars-grin.gov/gringlobal/taxonomydetail.aspx?id= 27031> (accessed April 4, 2019)

15.

Sebrae. O cultivo e o mercado de Guaraná (2010) Disponível em: https://www.sebrae.com.br/sites/PortalSebrae/artigos/o-cultivo-e-o-mercado-do-guarana,969a9e665b182410VgnVCM100000b272010aRCRD. Acesso em 25/03/2020

16.

Schimpl FC, Kiyota E, Mayer JLS, Gonçalves JFC et al (2014) Molecular and biochemical characterization of caffeine synthase and purine alkaloid concentration in guarana fruit. Phytochemistry 105:25–36. https://doi.org/10.1016/j.phytochem.2014.04.018CrossRefPubMed

17.

Schimpl F, Silva J, Gonçalves JF, Mazzafera P (2013) Guarana: revisiting a highly caffeinated plant from the Amazon. J Ethnopharmacol 150.https://doi.org/10.1016/j.jep.2013.08.023

18.

Hamerski L, Somner GV, Tamaio N (2013) PaulliniacupanaKunth (Sapindaceae): a review of its ethnopharmacology, phytochemistry and pharmacology. J Med Plants Res 7(30):2221–2229

19.

Kennedy DO, Haskell CF, Robertson B, Reay J, Brewster-Maund C, Luedemann J, . . ., Scholey AB (2008) Improved cognitive performance and mental fatigue following a multi-vitamin and mineral supplement with added guaraná (Paulliniacupana). Appetite 50(2-3): 506-513.https://doi.org/10.1016/j.appet.2007.10.007

20.

Moher D, Liberati A, Tetzlaff J, Altman DG (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8:336–341. https://doi.org/10.1016/j.ijsu.2010.02.007CrossRef

21.

Carvalho APV, Silva V, Grande AJ (2013) Avaliação do risco de viés de ensaios clínicos randomizados pela ferramenta da colaboração Cochrane. Diagn Tratamento 18:38–44

22.

Miranda VC, Trufelli DC, Fêde ÂB et al (2008) Guarana (Paullinia cupana) for chemotherapy-related fatigue. Einstein 6(2):195–199

23.

Miranda et al (2009) Guarana (Paulliniacupana) for chemotherapy-related fatigue. J Altern Complement Med Abr 15(4):431–3. https://doi.org/10.1089/acm.2008.0324CrossRef

24.

Albarnaz MD (2007) Efetividade do guaraná (paullinia cupana) para manejo da fadiga em mulheres com câncer de mama em quimioterapia : um ensaio clínico, duplo cego, randomizado. Universidade Federal do Goiás, Goiânia

25.

Trotti A, Colevas AD, Setser A et al (2003) CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13(3):176–181. https://doi.org/10.1016/S1053-4296(03)00031-6CrossRefPubMed

26.

Saad ED, Hoff PM, Carnelós RP, Katz A, Novis YAS, Pietrocola M, et al (2002) Critérios Comuns de Toxicidade do Instituto Nacional de Câncer dos Estados Unidos. Common toxicity criteria of the National Cancer Institute. 48(1): 63–96

27.

Passik SD, Kirsh KL, Donaghy K, Holtsclaw E, Theobald D, Cella D et al (2002) Barreiras relacionadas ao paciente para comunicação à fadiga: Validação inicial do questionário sobre barreiras de gerenciamento de fadiga. J Pain Symptom Manage 24:481–493CrossRef

28.

Meneses-Echávez JF, González-Jiménez E, Correa-Bautista JE, Valle J S-R, Ramírez-Vélez R (2015) Efectividad del ejercicio físico en la fatiga de pacientes con cáncer durante el tratamiento activo: revisión sistemática y metaanálisis. Cad Saúde Pública [Internet]. [citado 2020 Nov 11]; 31(4): 667–681. Disponível em: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2015000400667&lng=pt. https://doi.org/10.1590/0102-311X00114414

29.

Oberoi S, Robinson PD, Cataudella D, Culos-Reed SN, Davis H, Duong N, Gibson F, Götte M, Hinds P, Nijhof SL, Tomlinson D, van der Torre P, Cabral S, Dupuis LL, Sung L (2018) Physical activity reduces fatigue in patients with cancer and hematopoietic stem cell transplant recipients: a systematic review and meta-analysis of randomized trials. Crit Rev Oncol Hematol 122:52–59. https://doi.org/10.1016/j.critrevonc.2017.12.011CrossRefPubMed

30.

Lipsett A, Barrett S, Haruna F, Mustian K, Donovan AO (2017) The impact of exercise during adjuvant radiotherapy for breast cancer on fatigue and quality of life : a systematic review and meta-analysis. Breast 32:144–155

31.

Mohandas H et al (2017) Cancer-related fatigue treatment: an overview. J Câncer Res Ther 13:916–929PubMed

32.

National Comprehensive Cancer Network - NCCN. Cancer-related fatigue. 2018; Version 2.2018 – February 20, 2018

33.

Mock V, Atkinson A, Barsevick AM, Berger AM, Cimprich B, Eisenberger MA et al (2007) Cancer-related fatigue. Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 5(10):1054–78. Review

34.

Fan HG, Houédé-Tchen N, Yi QL, Chemerynsky I, Downie FP, Sabate K et al (2005) Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J Clin Oncol 23(31):8025–8032CrossRef

35.

Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK et al (1999) The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 85(5):1186–1196CrossRef

36.

Alexander S, Minton O, Stone PC (2009) Evaluation of screening instruments for cancer-related fatigue syndrome in breast cancer survivors. J Clin Oncol 27(8):1197–1201CrossRef

37.

Dux JP, Stalzer RF (1998) Managing safety in the chemical laboratory. Van Nostrand Reinhoild, New York

38.

Oliveira SS, Del Giglio AB, Lerner TG, Zanellato RM, Tiemi L, Reifur L, Santi PX, Del Giglio A (2013) Paulliniacupana para controle de ondas de calor em pacientes com câncer de mama: um estudopiloto. Einstein (São Paulo) 11(4):435–8. https://doi.org/10.1590/s1679-45082013000400005CrossRef

39.

Duke JA (1992) Handbook of phytochemical constituents of GRAS herbs and other economic plants. CRC Press, Boca Raton

Title: The use of guarana (Paullinia cupana) as a dietary supplement for fatigue in cancer patients: a systematic review with a meta-analysis
Authors: Daise Pereira de Araujo
Paula Tâmara Vieira Teixeira Pereira
Ariadina Jansen Campos Fontes
Karla Danielle Silva Marques
Érica Brandão de Moraes
Rosane Nassar Meireles Guerra
João Batista Santos Garcia
Publication date: 01-12-2021
Publisher: Springer Berlin Heidelberg
Keywords: Cancer Fatigue
Fatigue
Published in: Supportive Care in Cancer / Issue 12/2021
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-021-06242-5

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Methodology

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 12/2021

Applying the thresholds for clinical importance for fourteen key domains of the EORTC QLQ-C30: a latent class analysis of cancer survivors

Neuropsychological assessment in pediatric oncology survivorship care: utilization of services, results of evaluation, and educational and behavioral health outcomes

Antimicrobial prophylaxis and post-chemotherapy neutropenic fever in patients with leukemia: comparisons of C-reactive protein, procalcitonin and immediate fever outcome measures between those with and without prophylaxis, and the implications for practice

Designing a need-based program for relieving psychological distress of family caregivers of leukemia patients: a randomized controlled trial

“There’s somebody like me”: perspectives of a peer-to-peer gynecologic cancer mentorship program

Experiences with scans and scanxiety in people with advanced cancer: a qualitative study

Keynote webinar | Spotlight on antibody–drug conjugates in cancer